EUVIMEDEUVIMED entdecken
Crossref

GLP-1 receptor agonists as adjunct therapy in hidradenitis suppurativa: A hypothesis

Amir Feily

Int. Journal of Clinical Pharmacology and Therapeutics · 01.05.2026 · 64 (05) · 283-284

DOI: 10.5414/cp204935 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, erschienen am 01.05.2026. Verfasst von Amir Feily.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Feily, A. (2026). GLP-1 receptor agonists as adjunct therapy in hidradenitis suppurativa: A hypothesis. Int. Journal of Clinical Pharmacology and Therapeutics, 64(05), 283-284. https://doi.org/10.5414/cp204935

Vancouver

Feily A. GLP-1 receptor agonists as adjunct therapy in hidradenitis suppurativa: A hypothesis. Int. Journal of Clinical Pharmacology and Therapeutics. 2026;64(05):283-284. doi:10.5414/cp204935

BibTeX
@article{Feily2026,
  author = {Feily, Amir},
  title = {GLP-1 receptor agonists as adjunct therapy in hidradenitis suppurativa: A hypothesis},
  journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
  year = {2026},
  volume = {64},
  number = {05},
  pages = {283--284},
  doi = {10.5414/cp204935}
}
Kostenlos starten →